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Abstract
Background: Neuro-glial interactions are important for normal functioning of the brain as well as brain energy
metabolism. There are two major working models - in the classical view, both neurons and astrocytes can utilize
glucose as the energy source through oxidative metabolism, whereas in the astrocyte-neuron lactate shuttle
hypothesis (ANLSH) it is the astrocyte which can consume glucose through anaerobic glycolysis to pyruvate and
then to lactate, and this lactate is secreted to the extracellular space to be taken up by the neuron for further
oxidative degradation.
Results: In this computational study, we have included hypoxia-induced genetic regulation of these enzymes and
transporters, and analyzed whether the ANLSH model can provide an advantage to either cell type in terms of
supplying the energy demand. We have based this module on our own experimental analysis of hypoxia-
dependent regulation of transcription of key metabolic enzymes. Using this experimentation-supported in silico
modeling, we show that under both normoxic and hypoxic conditions in a given time period ANLSH model does
indeed provide the neuron with more ATP than in the classical view.
Conclusions: Although the ANLSH is energetically more favorable for the neuron, it is not the case for the
astrocyte in the long term. Considering the fact that astrocytes are more resilient to hypoxia, we would propose
that there is likely a switch between the two models, based on the energy demand of the neuron, so as to
maintain the survival of the neuron under hypoxic or glucose-and-oxygen-deprived conditions.
Background
Central and peripheral nervous system are composed of
glia (astrocytes, oligodentrocytes and microglia) and neu-
rons. Glia constitute 90% of the human brain cells; brain
constitute up to 2% of total body weight, and consume
about 20% of total body oxygen in the resting state. Reduc-
tion in the amount of oxygen in the blood (hypoxia) lead
to intracellular regulation changes in astrocytes and neu-
rons [1-3]. Glucose is usually considered the only carbon
source for cerebral energy metabolism. Only about 1% of
the total body glycogen is in the brain and it cannot be
used as carbohydrate reserve in the brain cells [4,5].
Reducing the amount of glucose taken from blood to the
brain leads to slow down of respiration and cerebral func-
tions. Brain tissues are more sensitive to hypoglycemia
when compared to the other organs. Glucose is taken to
the brain cells from blood and catabolized to pyruvate and
lactate in the cytoplasm, while oxidative respiration occurs
in mitochondria. In recent years evidence implied that this
compartmentalization may not be restricted to cytoplasm
and mitochondrion only, but may also extend to the cellu-
lar level. Recently proposed Astrocyte-Neuron Lactate
Shuttle Hypothesis (ANLSH) suggests that the glial glu-
cose metabolism is almost completely anaerobic, and that
the generated lactate which is released is transferred to
neurons [4,6]. Recent studies have shown that the exogen-
ous labeled lactate is a major substrate for oxidative meta-
bolism in C6 neuronal cell lines [7] and neurons are
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capable of utilizing glucose in addition to lactate, down to
CO2, whereas astroglial cells mainly metabolize glucose to
lactate and released into the medium [8]. It was further
shown that neurons cannot increase their rate of glycolysis
whereas astrocytes can, simply because they lack a crucial
glycolysis-promoting enzyme phosphofructokinase/fruc-
tose bisphosphatase, isoform 3 (PFKFB3) and glucose is
utilized mostly through the pentose phosphate pathway
generating glutathione and coping with oxidative stress,
thus suggesting that glucose serves more as a survival fac-
tor than an energy source in neurons [9].
There is, in fact, other shuttle systems operating in the
organisms - in the bee retina, for example, glucose is
metabolized exclusively in the glia, and mitochondria are
found exclusively in neurons [10]. In this system, glia were
found to supply alanine to the neurons, and neurons
return ammonium to the glia, suggesting a neuron-glia
alanine-ammonium shuttle, and this study further implies
lactate as a potential fuel supplied from the glia to the
neuron [10]. Interestingly, enzymes that would be crucial
to this shuttle, such as LDH, were shown to be regulated
in a sleep-dependent manner: one of the many functions
of sleep is supposed to be replenishing the energy stores in
the brain; molecules that are potentially involved in regu-
lating the lactate shuttle, such as LDH and GLUT1 in
astrocytes, were shown to be activated during sleep depri-
vation, and similarly lactate shuttle was increased in wake-
fulness [11].
Lactate is a metabolite used also in hypoxia and nor-
moxia in addition to anoxia, and lactate shuttle can be
found in a variety of tissues including muscle, where there
is a net flow of lactate from muscle to the blood, which is
then recovered from the blood by the resting muscle cell
and removed from the system by oxidation [12]. In the
brain, lactate was reported to be an immediate energy
source upon hypoxia; heart muscle is also an active consu-
mer of lactate, and in muscle tissue lactate can also be
taken up by the mitochondria by mitochondrial MCT
transporters to be converted into pyruvate and consumed
in the citric acid cycle [12]. Although not directly related
to the ANLSH, there is evidence that monocarboxylates
can act as rich energy sources for cells: cleavage-stage
embryos, for example, initially require pyruvate but they
switch to glucose as the preferred energy source as the
embryo develops into a morula [13]. Lactate and pyruvate
transport occurs via MCT transporters in the embryo, and
blastocysts actually demonstrate higher affinity to lactate
than zygotes [13]. As for neuronal cells, exogenous
13C-labeled lactate was shown to be a major substrate for
oxidative metabolism in C6 cell lines, and hypoxic condi-
tions were found to accumulate lactate as a rich energy
source [7].
Neurons and astrocytes both express glucose transpor-
ters (GLUTs), lactate transporters (monocarboxylate
transporters, MCTs), and lactate dehydrogenases
(LDHs), however the different isoforms expressed by
neurons or astrocytes seem to support the ANLSH
model [14,15]. MCTs transport monocarboxylates such
as pyruvate and lactate across plasma membrane or
even mitochondrial membranes as in the case of MCT1
or MCT2 [16]; MCT1 is mostly ubiquitous, while
MCT4 is mostly found in muscle cells or other metabo-
lically active cells including tumors, while MCT2 is
mostly found in kidney, neurons and sperm tails where
rapid uptake of low concentration substrates is required
[1]. MCT1, present in astrocytes, is known to be
involved in preferential release of lactate, whereas
MCT2, present in neurons, has been implied in the con-
sumption of lactate. In a different study using HeLa and
COS cells, it was shown that MCT4, but not MCT1,
was upregulated by HIF-1a in hypoxia. In adipocytes,
hypoxia was seen to upregulate MCT1 and MCT4 mes-
sage, while decreasing MCT2 expression [3].
Neurons and astrocytes also express different glucose
transporter isoforms - GLUT3 in neurons and GLUT1 in
astrocytes, with different kinetic properties [17]. Astro-
cytes were seen to increase glucose transport and utiliza-
tion in response to glutamergic activation. Likewise,
neurons and astrocytes also express different LDH iso-
forms - astrocytes predominantly express LDH5, which
produces lactate, while neurons express mostly LDH1,
which essentially converts lactate to pyruvate, supporting
the ANLSH model. Furthermore, lactate was shown to
help maintain neuronal activity during periods of hypo-
glycemia and hypoxia [17].
There are experimental and computational data for as
well as against the ANLSH - for example, some studies
imply that neurons with basal activation show no net
import of pyruvate or lactate [18], while Mangia and col-
leagues claim just the opposite of ANLSH, that is, neurons
shuttle the lactate into astrocytes, and the only way this
would work in reverse (ie astrocyte-to-neuron) is when
the astrocytic glucose transport capacity is increased 12-
fold [19]. As a matter of fact, it was shown that glutamate
can stimulate glycolysis in astrocytes, by stimulating
GLUT1 activity [20]. In this study, we model the brain
energy metabolism of neurons and astrocytes using a com-
putational model, incorporating genetic regulation of key
transporters and enzymes. Since some key components
(HK, GAPDH, PFK, PK, LDH, GLUT, MCT) of the meta-
bolic network are regulated in an oxygen-dependent man-
ner [[3,21]; and our data, see Results and Discussion],
we have incorporated the hypoxia-dependent regulation of
genetic networks to both neurons and astrocytes in our
model. As a matter of fact, oxygen and glucose were
shown to both act as signals for genetic regulation of cer-
tain regulatory molecules or enzymes in metabolic path-
ways - studies in liver, for instance, have shown that the
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glucose response element present within the pyruvate
kinase (PK) promoter acts as a convergence point for HIF-
1a, mediating crosstalk between glucose and oxygen sig-
nals [22]. It is successfully shown that hypoxia can in fact
upregulate glucose transporters up to 12-fold in the astro-
cyte, as predicted by Mangia et al [19], supporting that
ANLSH is feasible under energy-demanding conditions
such as hypoxia. Under conditions of brain ischemia neu-
rons were found to be more susceptible to damage than
astrocytes, mainly because astrocytes tend to maintain
large reserves of glycogen and can maintain glycolytic
ATP synthesis for a considerably longer time than neurons
[23]. Astrocytes were also shown to convert this glycogen
into lactate, which is then transferred to neurons under
periods of increased energy requirement or low glucose
availability [23]. Furthermore, ischemic conditions of myo-
cardial were shown to yield less ATP production and
accumulation of intracellular lactate [24].
In this study, we have modeled (reactions and numerical
values of the parameters are given in Additional File 1)
both views separately and assessed their ATP production
potential from a genetic regulation perspective, focusing
only on the production of ATP and not consumption. It
has to be emphasized that our model does not include any
ATP sinks that mimic use of ATP in the cells, leading to
non-physiological levels of ATP building up of the cell: we
have purposefully done so, in order to clearly observe the
accumulation of ATP over a period of time, since we are
only comparing the conventional view vs lactate shuttle in
terms of ATP production efficiency. Normally, neuronal
cells use the ATP in a number of processes including elec-
trical activity, transcription and translation, enzymatic
events, motor proteins in the cell etc, but none of these
events are included in this study so as to observe the
effects of the shuttle on ATP production. It must be noted
that hypoxia will also affect the metabolic rate of any cell,
therefore ATP will be used to different extents, which
would have complicated the interpretation of the results if
incorporated to the model.
In the first model, the classical view assumes that both
neurons and astrocytes can take up glucose and use it in
glycolysis and aerobic respiration (Figure 1). The pyruvate
can choose two routes - some of it will be transported into
mitochondria, converted into Acetyl Coenzyme A and
enter the citric acid cycle, whereas some will be converted
into lactate by lactate dehydrogenase (LDH) enzyme and
secreted into the extracellular matrix through a generic
monocarboxylate transporter, MCT (Figure 1).
The second model, ANLSH, assumes that glucose is
mainly taken up by the astrocyte and used up in glycoly-
sis, the resulting pyruvate is converted into lactate by the
astrocyte-specific LDH, and secreted out to the extracel-
lular matrix via astrocyte-specific MCT. This lactate in
turn is taken up by the neuron via the neuron-specific
MCT, and converted into pyruvate via neuron-specific
LDH, which is then free to enter the citric acid cycle in
mitochondria (Figure 2).
In both models, some of the key enzymes or transpor-
ters were modeled to be regulated in an oxygen-dependent
manner through Hypoxia Inducible Factor (HIF) both in
neurons and astrocytes (Figure 1). Available oxygen levels
are quite important for the survival of cells, and as such
cells have devised methods to sense oxygen levels and
respond accordingly. Heme-containing prolyl hydroxylase
enzymes (PHase) sense the levels of oxygen, and under
normoxic conditions interact with HIF1-a and hydroxylate
it on Proline residues, labeling it for proteasome-depen-
dent degradation [25]. Under hypoxic conditions, PHase
cannot interact with HIF1-a, which then accummulates
and translocates to the nucleus, where it regulates many
hypoxia-inducible genes [25].
In this study we have investigated the effects of hypoxia-
inducible transporters and enzymes, including GLUT,
MCT, HK, GAPDH, PFK, PK and LDH (see Materials and
Methods for details of the model), in the overall energetic
output of either model. It should be emphasized again that
this work focuses on the energetic output of the classical
view vs ANLSH in the presence of hypoxia-dependent reg-
ulation of key enzymes, irrespective of glutamergic activa-
tion or stimulation. Our results show that the ANLSH is
more advantageous for the neuron in terms of ATP pro-
duced, both under hypoxic and normoxic conditions,
although it does not provide a significant advantage for
the astrocyte. We therefore believe that rather than a
“classical-OR-ANLSH” choice for the cells, neurons and
astrocytes can switch between one model or the other,
depending on the energy requirements of the neuron.
Results and Discussion
Hypoxia-dependent regulation of key metabolic enzymes
Hypoxia-responsive nature of some metabolic enzymes or
transporters have been studied in different cell types such
as liver cells, adipocytes, HeLas or COS cells, as discussed
in Background, however the behavior of many of these
enzymes are still not completely known in cells of the ner-
vous system. In order to understand how some of the key
enzymes behave under hypoxic conditions in neuron-like
cells, we have used the PC12 cells, which are commonly
used as neuronal differentiation model as they can
undergo neuron-like physiological and molecular changes
in response to Nerve Growth Factor (NGF) or other sti-
mulants. To that end, we have studied enzymes such as
Pyruvate Kinase (PK), Hexokinase (HK), and the rate-lim-
iting enzyme phosphofructokinase (PFK), as well as the
first enzyme of the aerobic respiration, citrate synthase
(CS), that converts oxaloacetic acid and acetyl coA to citric
acid in the cycle. Intriguingly, all of these enzymes have
shown hypoxia-induced upregulation in transcription,
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albeit to different extents (Figure 3a). Glyceraldehyde
dehydrogenase (GAPDH) enzyme is generally used as an
internal control in RT-PCR reactions, however since it is
itself one of the enzymes of glycolysis, we have used two
different internal controls, GAPDH and b-actin, a cytoske-
letal component. We have found, to great surprise, that
widely-accepted internal control standard, GAPDH itself,
was hypoxia-induced, when the cDNAs were normalized
with respect to b-actin control (Figure 3a).
For that reason, as well as other reports in the literature
discussed above, we had incorporated such hypoxia-
dependent regulation to the transcription module of many
metabolic enzymes (see Materials and Methods for
details), and studied ATP production under normoxic vs
hypoxic conditions for the first time in this study. We
have next confirmed that our model indeed gives us
hypoxia-induced upregulation of these enzymes at both
mRNA and protein synthesis levels; the transcript and
protein of these enzymes were confirmed to respond to
hypoxia as expected (Figure 3b shows HK as an example;
it should be noted that all hypoxia-responsive genes listed
in Additional File 1 show the same kinetic profile upon
simulation). Since at this point we do not have absolute
kinetic parameters for the hypoxic regulation of each pro-
moter separately, in the model we have assumed similar
hypoxia-response kinetics, as shown in detail in Additional
File 1 and explained in Materials and Methods.
The energy efficiency of the classical view under both
normoxic and hypoxic conditions
We first investigated the energy efficiency of the classical
model under two different oxygen concentrations. Under
Figure 1 The classical view of energy metabolism within neurons and astrocytes. Blood glucose is transported and utilized by both cells
in glycolysis, and the resulting pyruvate is mainly converted to AcetylCoA within the mitochondria, to be broken down in citric acid cycle,
where NADH produced is converted to ATP in chemiosmosis. Some of the pyruvate is converted to lactate, however, and released into the
extracellular matrix. Glucose or lactate transporters as well as certain glycolytic and other enzymes were modeled to be regulated by hypoxia.
Transport across compartments are shown with dashed arrows. (Please note that the figures are simplified due to space constraints and not all
reactions are explicitly included; please refer to Additional File 1 for full set of reactions modeled; numbers in red correspond to the reaction
numbers in this file). GLUT, Glucose transporter; MCT, lactate transporter; HK, hexose kinase; PFK, phosphofructo kinase; GAPDH, glyceraldehyde-P-
dehydrogenase; PK, pyruvate kinase; LDH, lactate dehydrogenase; AcCoA, Acetyl coenzyme A; a-KG, alpha-ketoglutarate; SucCoA, succinyl
coenzyme A; Suc, succinate; Mal, malate; OxAc, oxaloacetate; ATP, adenosine triphosphate; NADH, G6P, glucose-6-phosphate; GAP,
glyceraldehyde-3-phosphate; BPG, bisphosphoglycerate; PHase, pyrolyl hydroxylase; HIF, hypoxia-inducible factor; Cr, creatine; P-Cr, phospho-
creatine.
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normoxic conditions in the classical model, glucose is
readily consumed, within the first 50 min, in both astro-
cytes and neurons (Figure 4a). This pathway results in
the production of lactate in both cell types, but although
lactate is quickly discarded out of the astrocyte within
around 30 min, very little lactate can be transported out
of the neuron due to the high amount of lactate buildup
in neuronal cytoplasm (Figure 4b). Very little extracellu-
lar lactate accumulates under these conditions (Figure
4b). It should be noted that, in our model, extracellular
lactate is not shuttled into the vascular endothelial cells
of the capillary, so as to focus on lactate shuttle between
only two cell types, the neuron and the astrocyte. Under
normoxia, most of the ATP is produced within the mito-
chondria around the same level in both neurons (reach-
ing a plateau of around 160 mM) and astrocytes
(reaching a plateau of around 140 mM) (Figure 4c). The
levels of ATP produced in the cytoplasm of astrocytes
and neurons, however, are different - neurons can pro-
duce up to 5 mM of ATP in cytoplasm through glycoly-
sis, whereas astrocytes can merely generate around
2.5 mM of ATP in their cytoplasm (Figure 4d). This is
not only a reflection of different volumes of cytoplasm in
astrocytes and neurons, since mitochondrial volumes dif-
fer by a similar ratio between the two cell types and yet
the amount of mitochondrial ATP synthesis is not signifi-
cantly different (see Additional File 1 for compartmental
volumes).
When both cells are exposed to hypoxic conditions, glu-
cose consumption is not changed significantly (Figure 5a)
in spite of the fact that GLUT and other enzymes are
overexpressed in an oxygen-dependent manner in the
model (Figure 3b), whereas lactate kinetics changes radi-
cally - very little lactate accumulates in both neuronal and
astrocytic cytoplasm, but the amount of extracellular lac-
tate rises to around 10 mM (Figure 5b). Although the
Figure 2 The astrocyte-neuron lactate shuttle hypothesis (ANLSH). In this model, glucose is mainly utilized by the astrocyte in glycolysis,
and the resulting pyruvate is converted to lactate and released to the extracellular matrix. This lactate is then taken up by the neuron,
converted into pyruvate, and utilized in aerobic respiration within the mitochondria. Transport across compartments are shown with dashed
arrows. (Please note that the figures are simplified due to space constraints and not all reactions are explicitly included; please refer to Additional
File 1 for full set of reactions modeled; numbers in red correspond to the reaction numbers in this file). GLUT, Glucose transporter; MCT, lactate
transporter; HK, hexose kinase; PFK, phosphofructo kinase; GAPDH, glyceraldehyde-P-dehydrogenase; PK, pyruvate kinase; LDH, lactate
dehydrogenase; AcCoA, Acetyl coenzyme A; a-KG, alpha-ketoglutarate; SucCoA, succinyl coenzyme A; Suc, succinate; Mal, malate; OxAc,
oxaloacetate; ATP, adenosine triphosphate; NADH, G6P, glucose-6-phosphate; GAP, glyceraldehyde-3-phosphate; BPG, bisphosphoglycerate;
PHase, pyrolyl hydroxylase; HIF, hypoxia-inducible factor; Cr, creatine; P-Cr, phospho-creatine.
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conditions are hypoxic, the mitochondria can still carry
out citric acid cycle to a large extent, but still the mito-
chondrial ATP production in the neuron is slightly
reduced to 120 mM in the neuron and 140 mM in the
astrocyte at steady-state conditions (Figure 5c). The cyto-
plasmic ATP levels are unaffected by the oxygen levels, as
expected from anaerobic glycolysis (Figure 5d).
The energy efficiency of the astrocyte-neuron lactate
shuttle hypothesis under normoxic, hypoxic, and glucose
starvation conditions
Next, the ANLSH is modeled as described in Figure 2,
where glucose is essentially taken up by the astrocyte and
consumed in glycolysis until pyruvate, which is then con-
verted into lactate and transported into the extracellular
matrix (Figure 2). Extracellular lactate is then taken up
by the neuron, converted to pyruvate and entered into
aerobic respiration in the neuron (Figure 2, see Materials
and Methods for details).
Under normoxic conditions with normal levels of glu-
cose, glucose intake is slightly increased in astrocytes (Fig-
ure 6a) as compared to that in classical model (Figure 4a).
On the other hand, since lactate generated by the astro-
cytes are transferred to the neurons to be converted into
pyruvate, there is no build-up of lactate in the neuronal
cytoplasm, unlike the steady-state levels of around 10 mM
Figure 3 Hypoxia-dependent regulation of key metabolic enzymes. (a) Reverse transcription - Polymerase Chain Reaction (PCR) results from
PC12 cells grown either in hypoxic or normoxic conditions. The transcript levels are studied for enzymes pyruvate kinase (PK), hexokinase (HK),
phosphofructokinase (PFK), citrate synthase (CS), Glyceraldehyde dehydrogenase (GAPDH), and b-actin (as internal control). (b) The kinetics of HK
mRNA and protein levels according to the classical model under normoxic and hypoxic conditions (normoxia = 7 mM O2, hypoxia = 0.35 mM
O2) as an example of hypoxia-responsive gene expression in the model. HK mRNA production kinetics in astrocytes (
An) under normoxic and
hypoxic condition is shown on the left panel, and HK protein production kinetics in astrocytes (Ac) under normoxic and hypoxic condition is
shown on the right panel. (Please note that all hypoxia-responsive genes have same rate equations, thus the same kinetic profiles in the model).
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cytoplasmic lactate in the classical view (Figure 4b), and
the relatively low levels of cytoplasmic lactate in neurons
rapidly declines within 1 hr to tolerable levels with the
ANLSH model (Figure 6b). Under these conditions, the
cytoplasmic ATP production in the astrocyte (just over 10
mM at steady-state; Figure 6c) is higher than that in the
classical view (around 2.5 mM at steady-state; Figure 6d).
The mitochondrial ATP production within neurons, how-
ever, is enhanced by over 3-fold in the ANLSH (over 500
mM as opposed to around 150 mM; compare Figure 6d
and 4c, respectively). It should be noted that neuronal
mitochondrial ATP levels reach the steady-state at 500
mM abruptly at around 300 min (inset to Figure 6d).
When the cells are simulated under hypoxic conditions
with the ANLSH model, it is observed that while glucose
consumption in the astrocyte does not seem to be affected
greatly (Figure 7), the amount of lactate produced declines
slightly (2 mM in the astrocyte as opposed to 2.5 mM in
normoxic conditions; Figure 7b vs Figure 6b, respectively).
The ATP produced in the astrocyte cytoplasm does not
change, reaching the same steady-state of 10 mM within
50 min (Figure 7c). The amount of ATP synthesized in the
neuronal mitochondria has a slower rate, reaching
300 mM by 250 min (Figure 7d), however when simula-
tion is run for longer periods it is observed that even
under hypoxic conditions the steady-state levels of
500 mM are reached but only at around 500 min (inset to
Figure 7d).
When the cells are placed in normoxic conditions with
glucose starvation, ie constant flow of 1 mM blood glu-
cose, glucose transport into the astrocyte is largely com-
promised due to higher intracellular glucose levels, which
is rapidly consumed (Figure 8a), leading to also a lower
level of lactate (Figure 8b) and ATP (Figure 8c and Figure
8d) production in the astrocyte as compared with Figure
6c and 7c). However, when the amount of lactate taken up
by the neuron is analyzed, the lactate levels are seen to
peak at around 2.5 mM under both normoxic and hypoxic
conditions irrespective of blood glucose levels (Figure 7b
and Figure 8b), albeit slightly lower than that in normoxic
conditions (around 3.5 mM, Figure 6b). Nevertheless, the
mitochondrial ATP production in the neuron shows a
much different profile under hypoxic vs normoxic-starva-
tion conditions: whereas under hypoxic conditions ATP
levels reach 500 mM at around 500 min, albeit with lower
rate (inset to Figure 6d and Figure 7d, respectively), under
Figure 4 The kinetics of glucose utilization, lactate production and ATP synthesis in neurons and astrocytes according to the classical
model under normoxic condition (Initial glucose concentration in the blood = 4.56 mM, oxygen concentration = 7 mM) (a) Glucose
consumption in neurons (Nc) and astrocytes (Ac); (b) Lactate kinetics in neurons (Nc), astrocytes (Ac) and the extracellular matrix (e); (c)
Mitochondrial ATP production in neurons (Nm) and astrocytes (Am); (d) Cytoplasmic ATP production in neurons (Nc) and astrocytes (Ac).
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Figure 5 The kinetics of glucose utilization, lactate production and ATP synthesis in neurons and astrocytes according to the classical
model under hypoxic condition (Initial glucose concentration in the blood = 4.56 mM, oxygen concentration = 0.35 mM); (a) Glucose
consumption in neurons (Nc) and astrocytes (Ac); (b) Lactate kinetics in neurons (Nc), astrocytes (Ac) and the extracellular matrix (e); (c)
Mitochondrial ATP production in neurons (Nm) and astrocytes (Am); (d) cytoplasmic ATP production in neurons (Nc) and astrocytes (Ac).
Figure 6 The kinetics of glucose utilization, lactate production and ATP synthesis in neurons and astrocytes according to the ANLSH
under normoxic condition (Initial glucose concentration in the blood = 4.56 mM, oxygen concentration = 7 mM); (a) Glucose
consumption in astrocytes (Ac); (b) Lactate kinetics in neurons (Nc), astrocytes (Ac) and the extracellular matrix (e); (c) ATP production
in astrocyte cytoplasm (Ac); (d) Mitochondrial ATP production in neurons (Nm); inset shows results from a longer simulation (500 min).
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Figure 7 The kinetics of glucose utilization, lactate production and ATP synthesis in neurons and astrocytes according to the ANLSH
under hypoxic condition (Initial glucose concentration in the blood = 4.56 mM, oxygen concentration = 0.35 mM); (a) Glucose
consumption in astrocytes (Ac); (b) Lactate kinetics in neurons (Nc), astrocytes (Ac) and the extracellular matrix (e); (c) ATP production
in astrocyte cytoplasm (Ac); (d) Mitochondrial ATP production in neurons (Nm); inset shows a longer simulation (500 min).
Figure 8 The kinetics of glucose utilization, lactate production and ATP synthesis in neurons and astrocytes according to the ANLSH
for starvation conditions (Initial glucose concentration in the blood = 1 mM (glucose starvation), oxygen concentration = 7 mM); (a)
Glucose consumption in astrocytes (Ac); (b) Lactate kinetics in neurons (Nc), astrocytes (Ac) and the extracellular matrix (e); (c) ATP
production in astrocyte cytoplasm (Ac); (d) Mitochondrial ATP production in neurons (Nm).
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normoxic-starvation conditions the ATP production
shows a biphasic profile, with a rapid increase in the first
20 min, then accumulating with a slower rate up until 200
min, at which point it reaches a steady-state at 400 mM
(Figure 8d).
Discussion
Our results indicate that under all three conditions stu-
died (normal glucose and normoxia; normal glucose and
hypoxia; low glucose and normoxia), ANLSH model
provides the neuron with on average around 3-fold
more mitochondrial ATP than under normoxia. Cyto-
plasmic ATP production in the astrocyte is also much
more using the ANLSH, around 2- to 4-fold, however it
should be noted that in ANLSH it is assumed that there
is no mitochondrial ATP production, hence the overall
astrocytic ATP production is significantly reduced
(around 150 mM using classical model vs around 10
mM using ANLSH). Oxygen and glucose deprivation
(OGD) was previously shown to decrease neuronal
NADH levels but not astrocytic ones, and neurons were
seen to be more susceptible to OGD-mediated cell
death [26]. In the same study, it was shown that hypoxia
was not detrimental to cells, but lack of glucose was
more crucial - indeed in our simulations normoxia vs
hypoxia does not change the levels of ATP significantly,
whereas decrease in glucose concentration has a serious
negative effect.
It must be emphasized that in this model glucose is
the limiting reactant, in other words it is not fed into
the blood continuously; furthermore the model is a time
course simulation not steady state, and there is no feed-
back inhibition on the glycolytic pathway. Therefore at
the end of the simulations glucose concentration
decreases as ATP gets produced. On the other hand,
lactate accumulates in the extracellular matrix, therefore
intracellular concentration decreases, or it shuttles into
the neuron and gets converted to pyruvate hence its
intracellular concentration decreases
Astrocytes were indeed reported to have 1 or 2 mito-
chondria [27], neurons have 10s of mitochondria [28],
which significantly increase the amount of ATP produced
in the neuron. In the present study all mitochondrial
activity was considered to be concentrated in a single
sub-compartment representing one mitochondrion per
cell (be it neuron or astrocyte). It should be also noted
that in the recent views of the shuttle hypothesis, astro-
cyte mitochondria are not considered to be completely
inactive; however the kinetic parameters regarding this
situation are not yet absolutely known at the single cell
level, therefore we have considered complete shutdown
of mitochondria in astrocytes. Under these conditions,
the amount of ATP produced in the astrocyte with the
ANLSH under any condition is very low, this ATP can
not sustain normal astrocytic functions for very long,
however it is certain that a temporary ANLSH would
benefit the neuron enormously even with a single mito-
chondrion; the output will be much higher for a neuron
with multiple mitochondria seen in vivo. Therefore, we
would like to propose that there is no strict classical-or-
ANLSH model choice in the brain, but rather a switch
based on energy demand of the neuron. It is also equally
likely that unlike in this model astrocytes do not comple-
tely switch off their aerobic respiration, but rather change
the ratio of pyruvate that is converted to lactate, thus
using an intermediate system between the classical view
and the ANLSH.
Conclusions
In this study, we have demonstrated that the ANLSH is
more advantageous for the neuron in terms of ATP pro-
duced, both under hypoxic and normoxic conditions,
although it does not provide a significant advantage for
the astrocyte. We therefore believe that rather than a
“classical-OR-ANLSH” choice for the cells, neurons and
astrocytes can switch between one model or the other,
depending on the energy requirements of the neuron.
However, more detailed, genome-wide kinetic models
will surely prove useful in analyzing these models in




COPASI 4.4.29 (COmplex PAthway SImulator) software
package was used for analysis [30]. In deterministic
modeling, the program solves differential equations
using the routine LSODE (Livermore Solver of Ordinary
Differential Equation).
Multi-Compartmental Models
To simulate the metabolic processes that occur inside
neuron and astrocyte during normoxia and hypoxia, a
general mathematical model was developed where cells
have interaction between capillary and extracellular area
with distinct volume of nucleus, cytosol and mitochon-
drion domains (Figures 1 and 2). For the sake of simpli-
city, total activity of the mitochondria were described as
a single sub-compartment both in neuron and astrocyte.
Compartment volumes are given in explanation of Addi-
tional File 1. The compartment volumes are the same in
both models: VNn = 0.033 L, VNc = 0.33 L, VNm = 0.0855
L, VAn = 0.019 L, VAc = 0.19L, VAm = 0.0475 L, Ve = 0.2
L, Vc = 0.095 L. ANLSH hypothesis suggests no itochon-
drion in the astrocytes, therefore the astrocyte mitochon-
drion volume is pertinent to the classical model only
[31-34]. Reactions with number 1-92 are pertinent to
model 1. Reactions with number 1-14, 16, 18-26, 28, 30,
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32, 34, 36, 38, 40, 42, 44, 46, 48, 50-56, 58, 60, 62, 64, 66,
68, 70-71, 73, 75, 77, 79, 81, 83, 85, 87, 89, 91, 93-94 are
pertinent to model 2 (Additional File 1). Between com-
partments (capillary-cytosol, cytosol-mitochondrion, and
nucleus-cytosol) molecular transport was assumed to
occur either by passive diffusion or carrier-mediated
transport between domains x and y and the transport
rate equations are given in Equations 1 and 2, respec-
tively. And all other reactions (such as X+Y ® Z+W) in
cells were assumed to obey Michaelis-Menten kinetics
rate law (Eqn.3) [20,21].
Transport Phenomena between compartments
a) Passive diffusion (O2, CO2)
Passive diffusion is linearly related to substrate concen-
trations on both sides of the cell membrane. However,
since this diffusion is a nonsaturable process, membrane
transport coefficient, membrane permeability and effec-
tive surface area are important parameters in transport
process and seen in the equation.
Jx→y = γx→y,j(Cx,j − σx→y,jCy,j) (1)
where gx®y, j is the membrane transport coefficient
and sx®y, j is the partition coefficient. Cx, j and Cy, j
are compartmental concentrations of species j.
b) Facilitated transport (glucose, lactate, pyruvate)
The rate of the facilitated transport can be defined by
using Michaelis Menten enzyme kinetics where Vx®y, j
is the transport rate coefficient, Km, x®y, j is the affinity











Numerical values of the biochemical parameters were
obtained mainly from previous experimental reports
(Additional File 1) and initial concentrations of the
metabolites (Additional File 1) were obtained from lit-
erature. Where no experimental data were available,
mathematical estimates, either from computational
reports or from our own estimations, were used in the
models. The detailed biochemical reactions for the two
models (classical view and ANLSH) in each cell are
defined and initial metabolite concentrations used for
the two models are listed in Additional File 1.
In this study, the energy metabolism in neuron and
astrocyte is investigated from two different perspectives.
One model is from the point of classical view (1st
Model, Additional File 1) and the other is from the
point of Astrocyte-Neuron lactate shuttle hypothesis
(ANLSH, 2nd Model, Additional File 1). For both mod-
els, we have analyzed the time-course data and results
were imported to MS Excel, and graphs have been gen-
erated using MS Excel.
The Model
The details of both models are given in Additional File 1
and the framework is given in Figures 1 and 2. The
metabolic part of the model is essentially based on the
model of Aubert and Costalat and Zhou et al., with the
exception of ion channels and neuronal stimulation
[33,34]. The hypoxia-dependent genetic regulation
aspects are modeled based on the work of Yucel and
Kurnaz [31].
In short, the classical view states that both neurons
and astrocytes can take up glucose from the blood
through a generic glucose transporter, GLUT, and use it
in glycolysis. Glucose is activated by addition of two
phosphates from ATP hydrolysis through action of Hex-
okinase (HK) and phosphofructokinase (PFK), and bro-
ken down (or “lysed”) to two glyceraldehyde-3-
phosphates (GAP), to be ultimately converted into pyru-
vate, generating 2 ATPs and 1 NADH from each GAP
(Figure 1). The NADH is generated by the action of
GAP dehydrogenase, or GAPDH, and one of the ATPs
is produced at the last step by pyruvate kinase, or PK.
The pyruvate then enters two different routes - some of
it will be transported into mitochondria, converted into
Acetyl Coenzyme A and enter the citric acid cycle,
whereas some will be converted into lactate by a generic
lactate dehydrogenase (LDH) enzyme and secreted into
the extracellular matrix through a generic monocarboxy-
late transporter, MCT (Figure 1). In either cell, some of
the above-mentioned key enzymes or transporters, ie
GLUT, PFK, GAPDH, PK, LDH and MCT [22,18] are
regulated in an oxygen-dependent manner through HIF
transcription factor (Figure 1).
In the astrocyte-neuron lactate shuttle hypothesis
(ANLSH), glucose is mainly taken up by the astrocyte
through the astrocyte-specific GLUT and used up in gly-
colysis, the resulting pyruvate is converted into lactate
by the astrocyte-specific LDH, and secreted out to the
extracellular matrix via astrocyte-specific MCT. This
lactate in turn is taken up by the neuron via the neu-
ron-specific MCT, and converted into pyruvate via neu-
ron-specific LDH, which is then free to enter the citric
acid cycle in mitochondria (Figure 2). This model, too,
incorporates oxygen-dependent regulation of some of
the enzymes and transporters as discussed in the first
model above.
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In both models, the mitochondrial reactions are mod-
eled in a similar manner; namely, pyruvate is taken into
the mitochondria, converted into Acetyl coenzyme A,
and entered into the citric acid cycle. The cycle pro-
duces GTP (assumed in this model to be essentially
equivalent to ATP), NADH and FADH2 (Figure 1). The
NADH and FADH2 is used as electron donors in the
electron transport chain (ETC), to ultimately produce
ATP (Figure 1); a simplified equation based on previous
models was used for modeling ETC (Additional File 1)
[6,34,35].
Experimental study of hypoxia-dependent gene
regulation
PC12 cells were maintained in DMEM containin 10%
Horse serum, 5%FBS, 1X L-Glutamine and 1X Penicil-
lin/Streptomycin. For hypoxia studies, cells were trans-
ferred to hypoxia incubator corresponding to 2% O2.
RNA was isolated from cells 3 days after plating (plating
density: 105cells/ml), following manufacturer’s instruc-
tions (Roche, High Pure RNA Isolation Kit). cDNA was
synthesized using Promega, ImProm-II™Reverse Tran-
scription System Kit. PCR reaction was carried out
using the primers listed in Table 1, at the indicated con-
ditions (typically, the reaction was performed in 30 ul,
with 0.5 ul dNTPs and 1 ul of each primer):
Additional material
Additional file 1: Equations which appear in both Model 1 and 2.
Biochemical reactions and kinetic parameters according to classical
view (Model 1) and ANLSH (Model 2). This file contains all the
reactions and equations used in the simulation of both models, as well
as the kinetic parameters and the references thereof.
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j : membrane transport coefficient; σx®y, j j : partition coefficient; Vx®y, j :
transport rate coefficient; Kx®y, j : affinity coefficient; Glc: glucose; GLUT:
glucose transporter; MCT: lactate transporter; HK: hexokinase; PFK:
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